Genes involved in human premature ovarian failure

Journal of Molecular Endocrinology

Volumn 45, Issue 5, 2010, Pages 257-279

  Persani, Luca ^a,b   Rossetti, Raffaella ^a   Cacciatore, Chiara ^b,c  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; FEMALE INFERTILITY; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; MENOPAUSE; OVARY FOLLICLE; PATHOGENESIS; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PUBERTY; REVIEW; X CHROMOSOME LINKED DISORDER;

AGE OF ONSET; AGING, PREMATURE; ANIMALS; FEMALE; GENES; GENES, X-LINKED; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GONADOTROPINS; HORMONE REPLACEMENT THERAPY; HUMANS; INFERTILITY, FEMALE; MENOPAUSE, PREMATURE; PRIMARY OVARIAN INSUFFICIENCY;

EID: 78649576457     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1677/JME-10-0070     Document Type: Review

References (212)

1. Aboura A, Dupas C, Tachdjian G, Portnoï MF, Bourcigaux N, Dewailly D, Frydman R, Fauser B, Ronci-Chaix N, Donadille B et al. 2009 Array comparative genomic hybridization profiling analysis reveals deoxyribonucleic acid copy number variations associated with premature ovarian failure. Journal of Clinical Endocrinology and Metabolism 94 4540-4546. (doi:10.1210/jc.2009-0186)
2. Achermann JC, Ito M, Ito M, Hindmarsh PC & Jameson JL 1999 A mutation in the gene encoding steroidogenic factor- 1 causes XY sex reversal and adrenal failure in humans. Nature Genetics 22 125-126. (doi:10.1038/9629) (Pubitemid 29264799)
3. Aittomaki K, Lucerna JL, Pakarinen P, Sistonen P, Tapanainen JS, Gromoll J, Kaskikari R, Sankila EM, Lehvaslaiho H & Engel AR 1995 Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82 959-968. (doi:10.1016/0092-8674(95)90275-9)
4. Albright F, Burnett CH & Smith CH 1942 Pseudohypoparathyroidism: an example of 'Sebright-Bantam syndrome'. Endocrinology 30 922-932.
5. Allen LA, Achermann JC, Pakarinen P, Kotlar TJ, Huhtaniemi IT, Jameson JL, Cheetham TD & Ball SG 2003 A novel loss of function mutation in exon 10 of the FSH receptor gene causing hypergonadotrophic hypogonadism: clinical and molecular characteristics. Human Reproduction 18 251-256. (doi:10.1093/humrep/ deg046)
6. Allen EG, Sullivan AK, Marcus M, Small C, Dominguez C, Epstein MP, Charen K, He W, Taylor KC & Sherman SL 2007 Examination of reproductive aging milestones among women who carry the FMR1 premutation. Human Reproduction 22 2142-2152. (doi:10.1093/humrep/dem148) (Pubitemid 47241859)
7. Attisano L, Silvestri C, Izzi L & Labbé E 2001 The transcriptional role of Smads and FAST (FoxH1) in TGFβ and activin signalling. Molecular and Cellular Endocrinology 180 3-11. (doi:10.1016/S0303- 7207(01)00524-X)
8. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T & Tagle D 1996 Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 12 159-171. (doi:10.1016/S0092-8674(00)80086-0)
9. Bashamboo A & McElreavey K 2010 NR5A1/SF-1 and development and function of the ovary. Annales d'Endocrinologie 71 177-182. (doi:10.1016/j.ando. 2010.02.013)
10. Beau I, Touraine P, Meduri G, Gougeon A, Desroches A, Matuchansky C, Milgrom E, Kuttenn F & Misrahi M 1998 A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. Journal of Clinical Investigation 102 1352-1359. (doi:10.1172/JCI3795) (Pubitemid 28467563)
11. Bennett CE, Conway GS, Macpherson JN, Jacobs PA & Murray A 2010 Intermediate sized CGG repeats are not a common cause of idiopathic premature ovarian failure. Human Reproduction 25 1335-1338. (doi:10.1093/humrep/deq058)
12. Beysen D, Raes J, Leroy BP, Lucassen A, Yates JR, Clayton-Smith J, Ilyina H, Brooks SS, Christin-Maitre S, Fellous M et al. 2005 Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndrome. American Journal of Human Genetics 77 205-218. (doi:10.1086/432083)
13. Beysen D, De Paepe A & De Baere E 2009 Mutation update: FOXL2 mutations and genomic rearrangements in BPES. Human Mutation 30 158-169. (doi:10.1002/humu.20807)
14. Bharath R, Unnikrishnan AG, Thampy MV, Anilkumar A, Nisha B, Praveen VP, Nair V, Jayakumar RV & Kumar H 2010 Turner syndrome and its variants. Indian Journal of Pediatrics 77 193-195. (doi:10.1007/s12098-009-0226-7)
15. Bione S, Sala C, Manzini C, Arrigo G, Zuffardi O, Banfi S, Borsani G, Jonveaux P, Philippe C, Zuccotti M et al. 1998 A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. American Journal of Human Genetics 62 533-541. (doi:10.1086/301761)
16. Bione S, Rizzolio F, Sala C, Ricotti R, Goegan M, Manzini MC, Battaglia R, Marozzi A, VegettiW, Dalprà R et al. 2004 Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B. Human Reproduction 19 2759-2766. (doi:10.1093/humrep/deh502)
17. Bodega B, Porta C, Crosignani PG, Ginelli E & Marozzi A 2004 Mutations in the coding region of the FOXL2 gene are not a major cause of idiopathic premature ovarian failure. Molecular Human Reproduction 10 555-557. (doi:10.1093/molehr/gah078)
18. Bodega B, Bione S, Dalprà L, Toniolo D, Ornaghi F, Vegetti W, Ginelli E & Marozzi A 2006 Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Human Reproduction 21 952-957. (doi:10.1093/humrep/dei432)
19. Boder E 1975 Ataxia-telangiectasia: some historic, clinical and pathologic observations. Birth Defects Original Article Series 11 255-270.
20. Bodin L, Di Pasquale E, Fabre S, Bontoux M, Monget P, Persani L & Mulsant P 2007 A novel mutation in the bone morphogenetic protein 15 gene causing defective protein secretion is associated with both increased ovulation rate and sterility in Lacaune sheep. Endocrinology 148 393-400. (doi:10.1210/en.2006-0764)
21. van Bokhoven H, Schwartz M, Andréasson S, van den Hurk JA, Bogerd L, Jay M, Rüther K, Jay B, Pawlowitzki IH, Sankila EM et al. 1994 Mutation spectrum in the CHM gene of Danish and Swedish choroideremia patients. Human Molecular Genetics 3 1047-1051. (doi:10.1093/hmg/3.7.1047)
22. Boltshauser E, Barth PG, Troost D, Martin E & Stallmach T 2002 "Vanishing white matter" and ovarian dysgenesis in an infant with cerebro-oculo-facio-skeletal phenotype. Neuropediatrics 33 57-62. (doi:10.1055/s-2002-32363)
23. Bretherick KL, Fluker MR & Robinson WP 2005 FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Human Genetics 117 376-382. (doi:10.1007/s00439-005-1326-8)
24. Burton KA, Van Ee CC, Purcell K, Winship I & Shelling AN 2000 Autosomal translocation associated with premature ovarian failure. Journal of Medical Genetics 37 e2. (doi:10.1136/jmg.37.5.e2)
25. Calderon FRO, Phansalkar AR, Crockett DK, Miller M & Mao R 2007 Mutation database for the galactose-1-phosphate uridyltransferase (GALT) gene. Human Mutation 28 939-943. (doi:10.1002/humu.20544) (Pubitemid 47519385)
26. Castrillon DH, Miao L, Kollipara R, Horner JW & DePinho RA 2003 Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 301 215-218. (doi:10.1126/science.1086336)
27. Cervato S, Mariniello B, Lazzarotto F, Morlin L, Zanchetta R, Radetti G, De Luca F, Valenzise M, Giordano R, Rizzo D et al. 2009 Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectodermal- dystrophy (APECED) and in their relatives. Clinical Endocrinology 70 421-428. (doi:10.1111/j.1365-2265. 2008.03318.x)
28. Chand AL, Ponnampalam AP, Harris SE, Winship IM & Shelling AN 2006 Mutational analysis of BMP15 and GDF9 as candidate genes for premature ovarian failure. Fertility and Sterility 86 1009-1012. (doi:10.1016/j.fertnstert.2006. 02.107)
29. Chand AL, Ooi GT, Harrison CA, Shelling AN & Robertson DM 2007 Functional analysis of the human inhibin alpha subunit variant A257T and its potential role in premature ovarian failure. Human Reproduction 22 3241-3248. (doi:10.1093/humrep/dem323)
30. Chand AL, Harrison CA & Shelling AN 2010 Inhibin and premature ovarian failure. Human Reproduction Update 16 39-50. (doi:10.1093/humupd/dmp031)
31. Chang H, Brown CW & Matzuk MM 2002 Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocrine Reviews 23 787-823. (doi:10.1210/er.2002-0003)
32. Conway GS, Kaltsas G, Patel A, Davies MC & Jacobs HS 1996 Characterization of idiopathic premature ovarian failure. Fertility and Sterility 65 337-341. (Pubitemid 26043830)
33. Cools M, Rooman RP, Wauters J, Jacqemyn Y & Du Caju MV 2004 A nonmosaic 45,X karyotype in a mother with Turner's syndrome and in her daughter. Fertility and Sterility 82 923-925. (doi:10.1016/j.fertnstert.2004.02.129)
34. Corre T, Schuettler J, Bione S, Marozzi A, Persani L, Rossetti R, Torricelli F, Giotti I, Vogt P, Toniolo D et al. 2009 A large-scale association study to assess the impact of known variants of the human INHA gene on premature ovarian failure. Human Reproduction 24 2023-2028. (doi:10.1093/humrep/dep090)
35. Coulam CB, Adamson SC & Annegers JF 1986 Incidence of premature ovarian failure. Obstetrics and Gynecology 67 604-606.
36. Cramer DW, Xu H & Harlow BL 1995 Family history as a predictor of early menopause. Fertility and Sterility 64 740-745.
37. Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P, Bisceglia L, Zelante L, Nagaraja R, Porcu S et al. 2001 The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nature Genetics 27 159-166. (doi:10.1038/84781)
38. Davis GH 2004 Fecundity genes in sheep. Animal Reproduction Science 82-83 247-253. (doi:10.1016/j.anireprosci.2004.04.001)
39. Davis CJ, Davison RM, Payne NN, Rodeck CH & Conway GS 2000 Female sex preponderance for idiopathic familial premature ovarian failure suggests an X chromosome defect: opinion. Human Reproduction 15 2418-2422. (doi:10.1093/humrep/15.11.2418)
40. De Baere E, Dixon MJ, Small KW, Jabs EW, Leroy BP, Devriendt K, Gillerot Y, Mortier G, Meire F, Van Maldergem L et al. 2001 Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype-phenotype correlation. Human Molecular Genetics 10 1591-1600. (doi:10.1093/hmg/10.15.1591) (Pubitemid 32734311)
41. De Baere E, Lemercier B, Christin-Maitre S, Durval D, Messiaen L, Fellous M & Veitia R 2002 FOXL2 mutation screening in a large panel of POF patients and XX males. Journal of Medical Genetics 39 e43. (doi:10.1136/jmg.39.8.e43)
42. De Baere E, Beysen D, Oley C, Lorenz B, Cocquet J, De Sutter P, Devriendt K, Dixon M, Fellous M, Fryns JP et al. 2003 FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation. American Journal of Human Genetics 72 478-487. (doi:10.1086/346118)
43. Demirhan O, Türkmen S, Schwabe GC, Soyupak S, Akgül E, Tastemir D, Karahan D, Mundlos S & Lehmann K 2005 A homozygous BMPR1B mutation causes a new subtype of acromesomelic chondrodysplasia with genital anomalies. Journal of Medical Genetics 42 314-317. (doi:10.1136/jmg.2004.023564)
44. Di Pasquale E, Beck-Peccoz P & Persani L 2004 Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. American Journal of Human Genetics 75 106-111. (doi:10.1086/422103)
45. Di Pasquale E, Rossetti R, Marozzi A, Bodega B, Borgato S, Cavallo L, Einaudi S, Radetti G, Russo G, Sacco M et al. 2006 Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. Journal of Clinical Endocrinology and Metabolism 91 1976-1979. (doi:10.1210/jc.2005-2650)
46. Dixit H, Deendayal M & Singh L 2004 Mutational analysis of the mature peptide region of inhibin genes in Indian women with ovarian failure. Human Reproduction 19 1760-1764. (doi:10.1093/humrep/deh342) (Pubitemid 39144618)
47. Dixit H, Rao LK, Padmalatha V, Kanakavalli M, Deenadayal M, Gupta N, Chakravarty B & Singh L 2005 Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure. Menopause 12 749-754. (doi:10.1097/01.gme.0000184424.96437.7a)
48. Dixit H, Rao LK, Padmalatha VV, Kanakavalli M, Deenadayal M, Gupta N, Chakrabarty B & Singh L 2006a Missense mutations in the BMP15 gene are associated with ovarian failure. Human Genetics 119 408-415. (doi:10.1007/s00439-006-0150-0)
49. Dixit H, Rao KL, Padmalatha V, Kanakavalli M, Deenadayal M, Gupta N, Chakravarty BN & Singh L 2006b Expansion of the germline analysis for the INHA gene in Indian women with ovarian failure. Human Reproduction 21 1643-1644. (doi:10.1093/humrep/del129)
50. Doherty E, Pakarinen P, Tiitinen A, Kiilavuori A, Huhtaniemi I, Forrest S & Aittomaki K 2002 A novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. Journal of Clinical Endocrinology and Metabolism 87 1151-1155. (doi:10.1210/jc.87.3.1151) (Pubitemid 36121080)
51. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N & Matzuk MM 1996 Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383 531-535. (doi:10.1038/383531a0)
52. Dube JL, Wang P, Elvin J, Lyons KM, Celeste AJ & Matzuk MM 1998 The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Molecular Endocrinology 12 1809-1817. (doi:10.1210/me.12.12.1809)
53. Elvin JA, Clark AT, Wang P, Wolfman NM & Matzuk MM 1999 Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Molecular Endocrinology 13 1035-1048. (doi:10.1210/me.13.6.1035) (Pubitemid 30645319)
54. Fabre S, Pierre A, Mulsant P, Bodin L, Di Pasquale E, Persani L, Monget P & Monniaux D 2006 Regulation of ovulation rate in mammals: contribution of sheep genetic models. Reproductive Biology and Endocrinology 4 20. (doi:10.1186/1477-7827-4-20)
55. Falorni A, Laureti S, Candeloro P, Perrino S, Coronella C, Bizzarro A, Santeusanio F & De Bellis A 2002 Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity. Fertility and Sterility 78 270-279. (doi:10.1016/S0015- 0282(02)03205-3)
56. Fechner PY, Davenport ML, Qualy RL, Ross JL, Gunther DF, Eugster EA, Huseman C, Zagar AJ, Quigley CA & Toddler Turner Study Group 2006 Differences in follicle-stimulating hormone secretion between 45,X monosomy Turner syndrome and 45,X/46,XX mosaicism are evident at an early age. Journal of Clinical Endocrinology and Metabolism 91 4896-4902. (doi:10.1210/jc.2006-1157)
57. Finnish-German APECED Consortium 1997 An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nature Genetics 17 399-403. (doi:10.1038/ng1297-399)
58. Fogli A, Rodriguez D, Eymard-Pierre E, Bouhour F, Labauge P,Meaney BF, Zeesman S, Kaneski CR, Schiffmann R & Boespflug-Tanguy O 2003 Ovarian failure related to eukaryotic initiation factor 2B mutations. American Journal of Human Genetics 72 1544-1550. (doi:10.1086/375404) (Pubitemid 36628393)
59. Fogli A, Gauthier-Barichard F, Schiffmann R, Vanderhoof VH, Bakalov VK, Nelson LM & Boespflug-Tanguy O 2004 Screening for known mutations in EIF2B genes in a large panel of patients with premature ovarian failure. BMC Women's Health 4 8. (doi:10.1186/1472-6874-4-8)
60. da Fonte Kohek MB, Batista MC, Russell AJ, Vass K, Giacaglia LR, Mendonca BB & Latronico AC 1998 No evidence of the inactivating mutation (C566T) in the follicle-stimulating hormone receptor gene in Brazilian women with premature ovarian failure. Fertility and Sterility 70 565-567. (doi:10.1016/S0015- 0282(98)00203-9)
61. Fraser IS, Russell P, Greco S & Robertson DM 1986 Resistant ovary syndrome and premature ovarian failure in young women with galactosaemia. Clinical Reproduction and Fertility 4 133-138.
62. Galloway SM, McNatty KP, Cambridge LM, Laitinen MPE, Juengel JL, Jokiranta TS, McLaren RJ, Luiro K, Dodds KG, Montgomery GW et al. 2000 Mutations in an oocyte-derived growth factor gene (bmp15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nature Genetics 25 279-283. (doi:10.1038/77033)
63. Gersak K, Harris SE, Smale WJ & Shelling AN 2004 A novel 30 bp deletion in the FOXL2 gene in a phenotypically normal woman with primary amenorrhoea: case report. Human Reproduction 19 2767-2770. (doi:10.1093/humrep/ deh496) (Pubitemid 40028945)
64. Ghadami M, Salama SA, Khatoon N, Chilvers R, Nagamani M, Chedrese PJ & Al-Hendy A 2008 Toward gene therapy of primary ovarian failure: adenovirus expressing human FSH receptor corrects the Finnish C566T mutation. Molecular Human Reproduction 14 9-15. (doi:10.1093/molehr/gam077)
65. Ghadami M, El-Demerdash E, Salama SA, Binhazim AA, Archibong AE, Chen X, Ballard BR, Sairam MR & Al-Hendy A 2010 Toward gene therapy of premature ovarian failure: intraovarian injection of adenovirus expressing human FSH receptor restores folliculogenesis in FSHR(-/-) FORKO mice. Molecular Human Reproduction 16 241-250. (doi:10.1093/molehr/gaq003)
66. Goswami D & Conway GS 2005 Premature ovarian failure. Human Reproduction Update 11 391-410. (doi:10.1093/humupd/dmi012)
67. Gubbels CS, Land JA & Rubio-GozalboME 2008 Fertility and impact of pregnancies on the mother and child in classic galactosemia. Obstetrical and Gynecological Survey 63 334-343. (doi:10.1097/OGX. 0b013e31816ff6c5)
68. Hanrahan JP, Gregan SM, Mulsant P, Mullen M, Davis GH, Powell R & Galloway SM 2004 Mutations in the genes for oocyte-derived growth factors GDF9 and BMP15 are associated with both increased ovulation rate and sterility in Cambridge and Belclare sheep (Ovis aries). Biology of Reproduction 70 900-909. (doi:10.1095/biolreprod.103.023093)
69. Harris SE, Chand AL, Winship IM, Gersak K, Aittomaki K & Shelling AN 2002 Identification of novel mutations in FOXL2 associated with premature ovarian failure. Molecular Human Reproduction 8 729-733. (doi:10.1093/molehr/8. 8.729)
70. Harris SE, Chand AL, Winship IM, Gersak K, Nishi Y, Yanase T, Nawata H & Shelling AN 2005 INHA promoter polymorphisms are associated with premature ovarian failure. Molecular Human Reproduction 11 779-784. (doi:10.1093/molehr/ gah219) (Pubitemid 43205485)
71. Hashimoto O, Moore RK & Shimasaki S 2005 Posttranslational processing of mouse and human BMP-15: potential implication in the determination of ovulation quota. PNAS 102 5426-5431. (doi:10.1073/pnas.0409533102)
72. He C, Kraft P, Chen C, Buring JE, Paré G, Hankinson SE, Chanock SJ, Ridker PM, Hunter DJ & Chasman DI 2009 Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nature Genetics 41 724-728. (doi:10.1038/ng.385)
73. Henrichsen CN, Chaignat E & Reymond A 2009 Copy number variants, diseases and gene expression. Human Molecular Genetics 18 R1-R8. (doi:10.1093/hmg/ddp011)
74. Hergersberg M, Matsuo K, Gassmann M, Schaffner W, Lüscher B, Rü licke T & Aguzzi A 1995 Tissue-specific expression of a FMR1/beta-galactosidase fusion gene in transgenic mice. Human Molecular Genetics 4 359-366. (doi:10.1093/hmg/4.3.359)
75. Hussein TS, Froiland DA, Amato F, Thompson JG & Gilchrist RB 2005 Oocytes prevent cumulus cell apoptosis by maintaining a morphogenic paracrine gradient of bone morphogenetic proteins. Journal of Cell Science 118 5257-5268. (doi:10.1242/jcs.02644)
76. Hussein TS, Thompson JG & Gilchrist RB 2006 Oocyte-secreted factors enhance oocyte developmental competence. Developmental Biology 296 514-521. (doi:10.1016/j.ydbio.2006.06.026)
77. Jaeken J, Kint J & Spaapen L 1992 Serum lysosomal enzyme abnormalities in galactosaemia. Lancet 340 1472-1473. (doi:10. 1016/0140-6736(92)92664-2)
78. Jeong HJ, Cho SW, Kim HA, Lee SH, Cho JH, Choi DH, Kwon H, Cha WT, Han JE & Cha KY 2004 G769A variation of inhibin alpha-gene in Korean women with premature ovarian failure. Yonsei Medical Journal 45 479-482. (Pubitemid 39010706)
79. Jiang M, Aittomäki K, Nilsson C, Pakarinen P, Iitiä A, Torresani T, Simonsen H, Goh V, Pettersson K, de la Chapelle A et al. 1998 The frequency of an inactivating point mutation (566C→T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry. Journal of Clinical Endocrinology and Metabolism 83 4338-4343. (doi:10.1210/jc.83.12.4338)
80. Jin P &Warren ST 2000 Understanding the molecular basis of fragile X syndrome. Human Molecular Genetics 9 901-908. (doi:10.1093/hmg/ 9.6.901)
81. Kang H, Lee SK, Kim MH, Song J, Bae SJ, Kim NK, Lee SH & Kwack K 2008 Parathyroid hormone-responsive B1 gene is associated with premature ovarian failure. Human Reproduction 23 1457-1465. (doi:10.1093/humrep/den086)
82. Kastan MB & Bartek J 2004 Cell-cycle checkpoints and cancer. Nature 432 316-323. (doi:10.1038/nature03097)
83. van der Knaap MS, Pronk JC & Scheper GC 2006 Vanihing white matter disease. Lancet Neurology 5 413-423. (doi:10.1016/S1474- 4422(06)70440-9)
84. Knauff EA, Franke L, van Es MA, van den Berg LH, van der Schouw YT, Laven JS, Lambalk CB, Hoek A, Goverde AJ, Christin-Maitre S et al. 2009 Genome-wide association study in premature ovarian failure patients suggests ADAMTS19 as a possible candidate gene. Human Reproduction 24 2372-2378. (doi:10.1093/humrep/ dep197)
85. Kornak U & Mundlos S 2003 Genetic disorders of the skeleton: a developmental approach. American Journal of Human Genetics 73 447-474. (doi:10.1086/377110) (Pubitemid 37076262)
86. Kovanci E, Rohozinski J, Simpson JL, Heard MJ, Bishop CE & Carson SA 2007 Growth differentiating factor-9 mutations may be associated with premature ovarian failure. Fertility and Sterility 87 143-146. (doi:10.1016/j.fertnstert. 2006.05.079)
87. Kovanci E, Simpson JL, Amato P, Rohozinski J, Heard MJ, Bishop CE & Carson SA 2008 Oocyte-specific G-protein-coupled receptor 3 (GPR3): no perturbations found in 82 women with premature ovarian failure (first report). Fertility and Sterility 90 1269-1271. (doi:10.1016/j.fertnstert.2007.07.1373)
88. Laissue P, Christin-Maitre S, Touraine P, Kuttenn F, Ritvos O, Aittomaki K, Bourcigaux N, Jacquesson L, Bouchard P, Frydman R et al. 2006 Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. European Journal of Endocrinology 154 739-744. (doi:10.1530/eje.1.02135)
89. Laissue P, Lakhal B, Benayoun BA, Dipietromaria A, Braham R, Elghezal H, Philibert P, Saâd A, Sultan C, Fellous M et al. 2009 Functional evidence implicating FOXL2 in non syndromic premature ovarian failure and in the regulation of the transcription factor OSR2. Journal of Medical Genetics 46 455-457. (doi:10.1136/ jmg.2008.065086)
90. Lakin ND, Weber P, Stankovic T, Rottinghaus ST, Taylor AM & Jackson SP 1996 Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene 13 2707-2716.
91. Latronico AC, Anasti J, Arnhold IJ, Rapaport R, Mendonca BB, Bloise W, Castro M, Tsigos C & Chrousos GP 1996 Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. New England Journal of Medicine 334 507-512. (doi:10.1056/ NEJM199602223340805)
92. Latronico AC, Chai Y, Arnhold IJ, Liu X, Mendonca BB & Segaloff DL 1998 A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor. Molecular Endocrinology 12 442-450. (doi:10.1210/me.12.3.442)
93. Layman LC 2006 Editorial: BMP15 - the first true ovarian determinant gene on the X-chromosome? Journal of Clinical Endocrinology and Metabolism 91 1673-1676. (doi:10.1210/jc.2006-0548)
94. Layman LC, Amde S, Cohen DP, Jin M & Xie J 1998 The Finnish follicle-stimulating hormone receptor gene mutation is rare in North American women with 46,XX ovarian failure. Fertility and Sterility 69 300-302. (doi:10.1016/S0015-0282(97)00480-9)
95. Ledent C, Demeestere I, Blum D, Petermans J, Hämäläinen T, Smits G & Vassart G 2005 Premature ovarian aging in mice deficient for Gpr3. PNAS 102 8922-8926. (doi:10.1073/pnas.0503840102)
96. Lehmann K, Seemann P, Stricker S, Sammar M, Meyer B, Süring K, Majewski F, Tinschert S, Grzeschik KH, Müller D et al. 2003 Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2. PNAS 100 12277-12282. (doi:10.1073/pnas. 2133476100)
97. Lin L, Philibert P, Ferraz-de-Souza B, Kelberman D, Homfray T, Albanese A, Molini V, Sebire NJ, Einaudi S, Conway GS et al. 2007 Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. Journal of Clinical Endocrinology and Metabolism 92 991-999. (doi:10.1210/jc.2006-1672)
98. Liu G, Hale GE & Hughes CL 2000 Galactose metabolism and ovarian toxicity. Reproductive Toxicology 14 377-384. (doi:10.1016/S0890- 6238(00)00096-4)
99. Liu L, Rajareddy S, Reddy P, Du C, Jagarlamudi K, Shen Y, Gunnarsson D, Selstam G, Boman K&Liu K 2007 Infertility caused by retardation of follicular development in mice with oocyte-specific expression of Foxo3a. Development 134 199-209. (doi:10.1242/dev.02667)
100. Livadas S, Xekouki P, Kafiri G, Voutetakis A, Maniati-Christidi M & Dacou-Voutetakis C 2005 Spontaneous pregnancy and birth of a normal female from a woman with Turner syndrome and elevated gonadotropins. Fertility and Sterility 83 769-772. (doi:10.1016/j. fertnstert.2004.11.007)
101. Loesch DZ, Bui QM, Huggins RM, Mitchell RJ, Hagerman RJ & Tassone F 2007 Transcript levels of the intermediate size or grey zone fragile X mental retardation 1 alleles are raised, and correlate with the number of CGG repeats. Journal of Medical Genetics 44 200-204. (doi:10.1136/jmg.2006.043950)
102. Lourenço D, Brauner R, Lin L, De Perdigo A, Weryha G, Muresan M, Boudjenah R, Guerra-Junior G, Maciel-Guerra AT, Achermann JC et al. 2009 Mutations in NR5A1 associated with ovarian insufficiency. New England Journal of Medicine 360 1200-1210. (doi:10.1056/ NEJMoa0806228)
103. Loutradis D, Patsoula E, Stefanidis K, Drakakis P, Antonakis G, Bletsa R, Antsaklis A & Michalas S 2006 Follicle-stimulating hormone receptor gene mutations are not evident in Greek women with premature ovarian failure and poor responders. Gynecologic and Obstetric Investigation 61 56-60. (doi:10.1159/000088658) (Pubitemid 43087554)
104. Luo X, Ikeda Y & Parker KL 1994 A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77 481-490. (doi:10.1016/0092-8674(94)90211-9)
105. Luoma P, Melberg A, Rinne JO, Kaukonen JA, Nupponen NN, Chalmers RM, Oldfors A, Rautakorpi I, Peltonen L, Majamaa K et al. 2004 Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 364 875-882. (doi:10.1016/S0140-6736(04) 16983-3)
106. Mandon-Pépin B, Touraine P, Kuttenn F, Derbois C, Rouxel A, Matsuda F, Nicolas A, Cotinot C & Fellous M 2008 Genetic investigation of four meiotic genes in women with premature ovarian failure. European Journal of Endocrinology 158 107-115. (doi:10.1530/EJE-07-0400) (Pubitemid 351211047)
107. Mansouri MR, Schuster J, Badhai J, Stattin EL, Lösel R, Wehling M, Carlsson B, Hovatta O, Karlström PO, Golovleva I et al. 2008 Alterations in the expression, structure and function of progesterone receptor membrane component-1 (PGRMC1) in premature ovarian failure. Human Molecular Genetics 17 3776-3783. (doi:10.1093/hmg/ddn274)
108. Mantovani G & Spada A 2006 Mutations in the Gs alpha gene causing hormone resistance. Best Practice and Research. Clinical Endocrinology and Metabolism 20 501-513. (doi:10.1016/j.beem.2006.09.001)
109. Mantovani G, Ballare E, Giammona E, Beck-Peccoz P & Spada A 2002 The gsalpha gene: predominant maternal origin of transcription in human thyroid gland and gonads. Journal of Clinical Endocrinology and Metabolism 87 4736-4740. (doi:10.1210/jc.2002-020183)
110. Marozzi A, Vegetti W, Manfredini E, Tibiletti MG, Testa G, Crosignani PG, Ginelli E, Meneveri R & Dalprà L 2000 Association between idiopathic premature ovarian failure and fragile X premutation. Human Reproduction 15 197-202. (doi:10.1093/humrep/15.1.197)
111. Marozzi A, Porta C, VegettiW, Crosignani PG, Tibiletti MG, Dalprà L& Ginelli E 2002 Mutation analysis of the inhibin alpha gene in a cohort of Italian women affected by ovarian failure. Human Reproduction 17 1741-1745. (doi:10.1093/humrep/17.7.1741) (Pubitemid 34790294)
112. Mathis D & Benoist C 2007 A decade of AIRE. Nature Reviews. Immunology 7 645-650. (doi:10.1038/nri2136)
113. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ & Bradley A 1992 Alphainhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360 313-319. (doi:10.1038/360313a0)
114. Matzuk MM, Finegold MJ, Mather JP, Krummen L, Lu H & Bradley A 1994 Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. PNAS 91 8817-8821. (doi:10. 1073/pnas.91.19.8817)
115. McNatty KP, Moore LG, Hudson NL, Quirke LD, Lawrence SB, Reader K, Hanrahan JP, Smith P, Groome NP, Laitinen M et al. 2004 The oocyte and its role in regulating ovulation rate: a new paradigm in reproductive biology. Reproduction 128 379-386. (doi:10.1530/rep. 1.00280)
116. McNatty KP,Galloway SM, Wilson T, Smith P, Hudson NL, O'Connell A, Bibby AH, Heath DA, Davis GH, Hanrahan JP et al. 2005 Physiological effects of major genes affecting ovulation rate in sheep. Genetics, Selection, Evolution 37 (Suppl 1) S25-S38. (doi:10.1186/ 1297-9686-37-S1-S25)
117. Méduri G, Bachelot A, Duflos C, Bständig B, Poirot C, Genestie C, Veitia R, De Baere E & Touraine P 2010 FOXL2 mutations lead to different ovarian phenotypes in BPES patients: case report. Human Reproduction 25 235-243. (doi:10.1093/humrep/dep355)
118. Mehlmann LM, Saeki Y, Tanaka S, Brennan TJ, Evsikov AV, Pendola FL, Knowles BB, Eppig JJ & Jaffe LA 2004 The Gs-linked receptor GPR3 maintains meiotic arrest in mammalian oocytes. Science 306 1947-1950. (doi:10.1126/ science.1103974) (Pubitemid 39627861)
119. Michels AW & Gottlieb PA 2010 Autoimmune polyglandular syndromes. Nature Reviews. Endocrinology 6 270-277. (doi:10.1038/ nrendo.2010.40)
120. Miller ME & Chatten J 1967 Ovarian changes in ataxia telangiectasia. Acta Paediatrica Scandinavica 56 559-561. (doi:10.1111/j.1651-2227. 1967.tb15424.x)
121. Montgomery GW, Zhao ZZ, Marsh AJ, Mayne R, Treloar SA, James M, Martin NG, Boomsma DI & Duffy DL 2004 A deletion mutation in GDF9 in sisters with spontaneous DZ twins. Twin Research 7 548-555. (doi:10.1375/1369052042663823)
122. Morabia A, Costanza MC & World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives 1998 International variability in ages at menarche, first livebirth, and menopause. American Journal of Epidemiology 148 1195-1205.
123. Mumm S, Herrera L, Waeltz PW, Scardovi A, Nagaraja R, Esposito T, Schlessinger D, Rocchi M & Forabosco A 2001 X/autosomal translocations in the Xq critical region associated with premature ovarian failure fall within and outside genes. Genomics 76 30-36. (doi:10.1006/geno.2001.6611)
124. Murabito JM, Yang Q, Fox C, Wilson PW & Cupples LA 2005 Heritability of age at natural menopause in the Framingham Heart Study. Journal of Clinical Endocrinology and Metabolism 90 3427-3430. (doi:10.1210/jc.2005-0181) (Pubitemid 41014308)
125. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJE, Lalioti MD, Mullis PE, Antonarakis SE et al. 1997 Positional cloning of the APECED gene. Nature Genetics 17 393-398. (doi:10.1038/ng1297-393)
126. Nakamura Y, Maekawa R, Yamagata Y, Tamura I & Sugino N 2008 A novel mutation in exon8 of the follicle-stimulating hormone receptor in a woman with primary amenorrhea. Gynecological Endocrinology 24 708-712. (doi:10.1080/ 09513590802454927)
127. Nallathambi J, Moumné L, De Baere E, Beysen D, Usha K, Sundaresan P & Veitia R 2007 A novel polyalanine expansion in FOXL2: the first evidence for a recessive form of the blepharophimosis syndrome (BPES) associated with ovarian dysfunction. Human Genetics 121 107-112. (doi:10.1007/s00439-006-0276-0)
128. Nallathambi J, Laissue P, Batista F, Benayoun BA, Lesaffre C, Moumné L, Pandaranayaka PE, Usha K, Krishnaswamy S, Sundaresan P et al. 2008 Differential functional effects of novel mutations of the transcription factor FOXL2 in BPES patients. Human Mutation 29 E123-E131. (doi:10.1002/humu. 20809)
129. Nelson LM 2009 Clinical practice. Primary ovarian insufficiency. New England Journal of Medicine 360 606-614. (doi:10.1056/ NEJMcp0808697)
130. Ogata T & Matsuo N 1995 Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features. Human Genetics 95 607-629. (doi:10.1007/BF00209476)
131. Oldenburg RA, van Dooren MF, de Graaf B, Simons E, Govaerts L, Swagemakers S, Verkerk JM, Oostra BA & Bertoli-Avella AM 2008 A genome-wide linkage scan in a Dutch family identifies a premature ovarian failure susceptibility locus. Human Reproduction 23 2835-2841. (doi:10.1093/humrep/ den278)
132. Oostra BA & Willemsen R 2003 A fragile balance: FMR1 expression levels. Human Molecular Genetics 12 (Spec. No. 2) R249-R257. (doi:10.1093/hmg/ddg298)
133. Ornstein KS, McGuire EJ, Berry GT, Roth S & Segal S 1992 Abnormal galactosylation of complex carbohydrates in cultured fibroblasts from patients with galactose-1-phosphate uridyltransferase deficiency. Pediatric Research 31 508-511. (doi:10.1203/00006450- 199205000-00020)
134. Pagnamenta AT, Taanman JW, Wilson CJ, Anderson NE, Marotta R, Duncan AJ, Bitner-Glindzicz M, Taylor RW, Laskowski A, Thorburn DR et al. 2006 Dominant inheritance of premature ovarian failure associated with mutant mitochondrial DNA polymerase gamma. Human Reproduction 21 2467-2473. (doi:10.1093/humrep/ del076) (Pubitemid 44542135)
135. Palmer JS, Zhao ZZ, Hoekstra C, Hayward NK, Webb PM, Whiteman DC, Martin NG, Boomsma DI, Duffy DL & Montgomery GW 2006 Novel variants in growth differentiation factor 9 in mothers of dizygotic twins. Journal of Clinical Endocrinology and Metabolism 91 4713-4716. (doi:10.1210/jc.2006-0970)
136. Pasquino AM, Passeri F, Pucarelli I, Segni M & Municchi G 1997 Spontaneous pubertal development in Turner's syndrome. Italian Study Group for Turner's syndrome. Journal of Clinical Endocrinology and Metabolism 82 1810-1813. (doi:10.1210/jc.82.6.1810)
137. Paterson P & Peltonen L 2005 Autoimmune polyendocrinopathy syndrome type 1 (APS1) 963 and AIRE gene: new views on molecular basis of autoimmunity. Journal of Autoimmunity 25 49-55. (doi:10.1016/j.jaut.2005.09.022)
138. Patten JL & Levine MA 1990 Immunochemical analysis of the alpha-subunit of the stimulatory G-protein of adenylyl cyclase in patients with Albright's hereditary osteodystrophy. Journal of Clinical Endocrinology and Metabolism 71 1208-1214. (doi:10.1210/ jcem-71-5-1208)
139. Perheentupa J 1996 Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Hormone and Metabolic Research 28 353-356. (doi:10.1055/s-2007-979814)
140. Perry JR, Stolk L, Franceschini N, Lunetta KL, Zhai G, McArdle PF, Smith AV, Aspelund T, Bandinelli S, Boerwinkle E et al. 2009 Meta-analysis of genome-wide association data identifies two loci influencing age at menarche. Nature Genetics 41 648-650. (doi:10. 1038/ng.386)
141. Persani L, Rossetti R, Cacciatore C & Bonomi M 2009 Primary ovarian insufficiency: X chromosome defects and autoimmunity. Journal of Autoimmunity 33 35-41. (doi:10.1016/j.jaut.2009.03.004)
142. Pisarska MD, Bae J, Klein C & Hsueh AJ 2004 Forkhead l2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene. Endocrinology 145 3424-3433. (doi:10.1210/en.2003-1141) (Pubitemid 38830015)
143. Prakash GJ, Kanth VV, Shelling AN, Rozati R & Sujatha M 2009 Absence of 566C>T mutation in exon 7 of the FSHR gene in Indian women with premature ovarian failure. International Journal of Gynecology and Obstetrics 105 265-266. (doi:10.1016/j.ijgo. 2009.01.023)
144. Prakash GJ, Ravi Kanth VV, Shelling AN, Rozati R & Sujatha M 2010 Mutational analysis of inhibin alpha gene revealed three novel variations in Indian women with premature ovarian failure. Fertility and Sterility 94 90-98. (doi:10.1016/j.fertnstert.2009.02.014)
145. Prueitt RL & Zinn AR 2001 A fork in the road to fertility. Nature Genetics 27 132-134. (doi:10.1038/84735)
146. Prueitt RL, Ross JL & Zinn AR 2000 Physical mapping of nine Xq translocation breakpoints and identification of XPNPEP2 as a premature ovarian failure candidate gene. Cytogenetics and Cell Genetics 89 44-50. (doi:10.1159/000015560)
147. Prueitt RL, Chen H, Barnes RI & Zinn AR 2002 Most X; autosome translocations associated with premature ovarian failure do not interrupt X-linked genes. Cytogenetic and Genome Research 97 32-38. (doi:10.1159/ 000064052)
148. Qin Y, Choi Y, Zhao H, Simpson JL, Chen ZJ & Rajkovic A 2007 NOBOX homeobox mutation causes premature ovarian failure. American Journal of Human Genetics 81 576-581. (doi:10.1086/ 519496)
149. Qin Y, Shi Y, Zhao Y, Carson SA, Simpson JL & Chen ZJ 2009 Mutation analysis of NOBOX homeodomain in Chinese women with premature ovarian failure. Fertility and Sterility 91 1507-1509. (doi:10.1016/j.fertnstert.2008.08.020)
150. Quilter CR, Karcanias AC, Bagga MR, Duncan S, Murray A, Conway GS, Sargent CA & Affara NA 2010 Analysis of X chromosome genomic DNA sequence copy number variation associated with premature ovarian failure (POF). Human Reproduction 25 2139-2150. (doi:10.1093/humrep/deq158)
151. Raile K, Stobbe H, Tröbs RB, Kiess W & Pfäffle R 2005 A new heterozygous mutation of the FOXL2 gene is associated with a large ovarian cyst and ovarian dysfunction in an adolescent girl with blepharophimosis/ptosis/ epicanthus inversus syndrome. European Journal of Endocrinology 153 353-358. (doi:10.1530/eje.1. 01974)
152. Rajkovic A, Pangas SA, Ballow D, Suzumori N & Matzuk MM 2004 NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression. Science 305 1157-1159. (doi:10. 1126/science.1099755)
153. Rannikko A, Pakarinen P, Manna PR, Beau I, MisrahiM, Aittomäki K & Huhtaniemi I 2002 Functional characterization of the human FSH receptor with an inactivating Ala189Val mutation. Molecular Human Reproduction 8 311-317. (doi:10.1093/molehr/8.4.311)
154. Reynaud K, Cortvrindt R, Verlinde F, De Schepper J, Bourgain C & Smitz J 2004 Number of ovarian follicles in human fetuses with the 45,X karyotype. Fertility and Sterility 81 1112-1119. (doi:10.1016/ j.fertnstert.2003.12.011)
155. Rifé M, Badenas C, Quintó L, Puigoriol E, Tazón B, Rodriguez-Revenga L, Jiménez L, Sánchez A & Milà M 2004 Analysis of CGG variation through 642 meioses in fragile X families. Molecular Human Reproduction 10 773-776. (doi:10.1093/molehr/gah102) (Pubitemid 39341600)
156. Rizzolio F, Bione S, Sala C, Goegan M, Gentile M, Gregato G, Rossi E, Pramparo T, Zuffardi O & Toniolo D 2006 Chromosomal rearrangements in Xq and premature ovarian failure: mapping of 25 new cases and review of the literature. Human Reproduction 21 1477-1483. (doi:10.1093/humrep/dei495)
157. Rizzolio F, Sala C, Alboresi S, Bione S, Gilli S, Goegan M, Pramparo T, Zuffardi O & Toniolo D 2007 Epigenetic control of the critical region for premature ovarian failure on autosomal genes translocated to the X chromosome: a hypothesis. Human Genetics 121 441-450. (doi:10.1007/s00439-007-0329-z)
158. Rizzolio F, Pramparo T, Sala C, Zuffardi O, De Santis L, Rabellotti E, Calzi F, Fusi F, Bellazzi R & Toniolo D 2009 Epigenetic analysis of the critical region I for premature ovarian failure: demonstration of a highly heterochromatic domain on the long arm of the mammalian X chromosome. Journal of Medical Genetics 46 585-592. (doi:10.1136/jmg.2007.056093)
159. Robinson ACR, Dockeray CJ, Cullen MJ & Sweeney EC 1984 Hypergonadotrophic hypogonadism in classical galactosaemia: evidence for defective oogenesis: case report. British Journal of Obstetrics and Gynaecology 91 199-200.
160. Rossetti R, Di Pasquale E, Marozzi A, Bione S, Toniolo D, Grammatico P, Nelson LM, Beck-Peccoz P & Persani L 2009 BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive protein. Human Mutation 30 804-810. (doi:10.1002/humu.20961)
161. Rubio-Gozalbo ME, Panis B, Zimmermann LJI, Spaapen LJ & Menheere PPCA 2006 The endocrine system in treated patients with classical galactosemia. Molecular Genetics and Metabolism 89 316-322. (doi:10.1016/j.ymgme.2006.07.005) (Pubitemid 44692539)
162. Rubio-Gozalbo ME, Gubbels CS, Bakker JA, Menheere PP, Wodzig WK & Land JA 2010 Gonadal function in male and female patients with classic galactosemia. Human Reproduction Update 16 177-188. (doi:10.1093/humupd/dmp038)
163. Sauer MV, Kaufman FR, Paulson RJ & Lobo RA 1991 Pregnancy after oocyte donation to a woman with ovarian failure and classical galactosemia. Fertility and Sterility 55 1197-1199.
164. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S et al. 1995 A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268 1749-1753. (doi:10.1126/science. 7792600)
165. Schiffmann R, Tedeschi G, Kinkel RP, Trapp BD, Frank JA, Kaneski CR, Brady RO, Barton NW, Nelson L & Yanovski JA 1997 Leukodystrophy in patients with ovarian dysgenesis. Annals of Neurology 41 654-661. (doi:10.1002/ana. 410410515)
166. Schlessinger D, Herrera L, Crisponi L, Mumm S, Percesepe A, Pellegrini M, Pilia G & Forabosco A 2002 Genes and translocations involved in POF. American Journal of Medical Genetics 111 328-333. (doi:10.1002/ajmg.10565)
167. Schmidt D, Ovitt CE, Anlag K, Fehsenfeld S, Gredsted L, Treier AC & Treier M 2004 The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 131 933-942. (doi:10.1242/dev.00969)
168. Schwarz HP, Moser H, Schild J & Zuppinger K 1984 Hypergonadotropic hypogonadism in two sisters with galactosaemia. Archives of Disease in Childhood 59 781-783. (doi:10.1136/adc.59.8.781)
169. Sedgwick RP & Boder E 1991 Ataxia-telangiectasia. In Handook of Clinical Neurology, pp 347-423. Eds P Vinken, G Bruyn & H Klawans. New York: Elsevier.
170. Shelling AN, Burton KA, Chand AL, van Ee CC, France JT, Farquhar CM, Milsom SR, Love DR, Gersak K, Aittomäki K et al. 2000 Inhibin: a candidate gene for premature ovarian failure. Human Reproduction 15 2644-2649. (doi:10.1093/humrep/15.12.2644)
171. Shiloh Y 2003 ATM and related protein kinases: safeguarding genome integrity. Nature Reviews. Cancer 3 155-168. (doi:10.1038/nrc1011) (Pubitemid 37328868)
172. Shimasaki S, Moore RK, Otsuka F & Erickson GF 2004 The bone morphogenetic protein system in mammalian reproduction. Endocrine Reviews 25 72-101. (doi:10.1210/er.2003-0007)
173. Simpson JL 2008 Genetic and phenotypic heterogeneity in ovarian failure: overview of selected candidate genes. Annals of the New York Academy of Sciences 1135 146-154. (doi:10.1196/annals. 1429.019)
174. Sparks SE & Krasnewich DM 2009 Congenital disorders of glycosylation overview. In Gene Reviews. Eds RA Pagon, TC Bird, CR Dolan & K Stephens. Seattle: University of Washington.
175. Steinmann B, Gitzelmann R & Zachmann M 1981 Hypogonadism and galactosemia. New England Journal of Medicine 305 464-465. (doi:10.1056/ NEJM198111193052127)
176. Sundblad V, Chiauzzi VA, Andreone L, Campo S, Charreau EH & Dain L 2006 Controversial role of inhibin alpha-subunit gene in the aetiology of premature ovarian failure. Human Reproduction 21 1154-1160. (doi:10.1093/humrep/ dei452)
177. Sybert VP & McCauley E 2004 Turner's syndrome. New England Journal of Medicine 351 1227-1238. (doi:10.1056/NEJMra030360)
178. Takebayashi K, Takakura K, Wang H, Kimura F, Kasahara K & Noda Y 2000 Mutation analysis of the growth differentiation factor-9 and - 9B genes in patients with premature ovarian failure and polycystic ovary syndrome. Fertility and Sterility 74 976-979. (doi:10.1016/S0015-0282(00)01539-9)
179. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE & Hagerman PJ 2000 Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. American Journal of Human Genetics 66 6-15. (doi:10.1086/302720)
180. Tavtigian SV, Oefner PJ, Babikyan D, Hartmann A, Healey S, Le Calvez-Kelm F, Lesueur F, Byrnes GB, Chuang SC, Forey N et al. 2009 Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. American Journal of Human Genetics 85 427-446. (doi:10.1016/j.ajhg.2009.08.018)
181. Tedesco TA & Miller KL 1979 Galactosemia: alterations in sulfate metabolism secondary to galactose-1-phosphate uridyltransferase deficiency. Science 205 1395-1397. (doi:10.1126/science.472754)
182. Themmen APN & Huhtaniemi IT 2000 Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocrine Reviews 21 551-583. (doi:10.1210/er.21.5. 551)
183. Therman E, Laxova R & Susman B 1990 The critical region on the human Xq. Human Genetics 85 455-461. (doi:10.1007/BF00194216)
184. Tibiletti MG, Testa G, Vegetti W, Alagna F, Taborelli M, Dalprà L, Bolis PF & Crosignani PG 1999 The idiopathic forms of premature menopause and early menopause show the same genetic pattern. Human Reproduction 14 2731-2734. (doi:10.1093/humrep/14.11.2731) (Pubitemid 29520682)
185. Timmreck LS & Reindollar RH 2003 Contemporary issues in primary amenorrhea. Obstetrics and Gynecology Clinics of North America 30 287-302. (doi:10.1016/S0889-8545(03)00027-5)
186. Tiotiu D, Mercadal BA, Imbert R, Verbist J, Demeestere I, De Leener A, Englert Y, Vassart G, Costagliola S & Delbaere A 2010 Variants of the BMP15 gene in a cohort of patients with premature ovarian failure. Human Reproduction 25 1581-1587. (doi:10.1093/humrep/deq073)
187. Toniolo D 2006 X-linked premature ovarian failure: a complex disease. Current Opinion in Genetics&Development 16 293-300. (doi:10.1016/ j.gde.2006.04.005)
188. Torgerson DJ, Thomas RE & Reid DM 1997 Mothers and daughters menopausal ages: is there a link? European Journal of Obstetrics, Gynecology, and Reproductive Biology 74 63-66. (doi:10.1016/S0301- 2115(97)00085-7)
189. Touraine P, Beau I, Gougeon A, Meduri G, Desroches A, Pichard C, Detoeuf M, Paniel B, Prieur M, Zorn JR et al. 1999 New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. Molecular Endocrinology 13 1844-1854. (doi:10.1210/me.13.11.1844)
190. Tyfield L, Reichardt J, Fridovich-Keil J, Croke DT, Elsas LJ, Strobl W, Kozak L, Coskun T, Novelli G & Okano Y 1999 Classical galactosemia and mutations at the galactose-1-phosphate uridyl transferase (GALT) gene. Human Mutation 13 417-430. (doi:10.1002/ (SICI)1098-1004(1999)13:6〈417::AID- HUMU1〉3.0.CO;2-0)
191. Uda M, Ottolenghi C, Crisponi L, Garcia JE, Deiana M, Kimber W, Forabosco A, Cao A, Schlessinger D & Pilia G 2004 Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Human Molecular Genetics 13 1171-1181. (doi:10.1093/hmg/ddh124)
192. Vegetti W, Grazia Tibiletti M, Testa G, de Lauretis Yankowski, Alagna F, Castoldi E, Taborelli M, Motta T, Bolis PF, Dalprá L et al. 1998 Inheritance in idiopathic premature ovarian failure: analysis of 71 cases. Human Reproduction 13 1796-1800. (doi:10.1093/humrep/ 13.7.1796) (Pubitemid 28393456)
193. Vinci G, Christin-Maitre S, Pasquier M, Bouchard P, Fellous M & Veitia RA 2008 FOXO3a variants in patients with premature ovarian failure. Clinical Endocrinology 68 495-497. (doi:10.1111/j. 1365-2265.2007.03052.x)
194. Voorhuis M, Onland-Moret NC, van der Schouw YT, Fauser BC & Broekmans FJ 2010 Human studies on genetics of the age at natural menopause: a systematic review. Human Reproduction Update 16 364-377. (doi:10.1093/humupd/dmp055)
195. Waggoner DD, Buist NR & Donnell GN 1990 Long-term prognosis in galactosaemia: results of a survey of 350 cases. Journal of Inherited Metabolic Disease 13 802-818. (doi:10.1007/ BF01800204)
196. Wang B, Wen Q, Ni F, Zhou S, Wang J, Cao Y & Ma X 2010 Analyses of growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) mutation in Chinese women with premature ovarian failure. Clinical Endocrinology 72 135-136. (doi:10.1111/j. 1365-2265.2009.03613.x)
197. Watkins WJ, Umbers AJ, Woad KJ, Harris SE, Winship IM, Gersak K & Shelling AN 2006 Mutational screening of FOXO3A and FOXO1A in women with premature ovarian failure. Fertility and Sterility 86 1518-1521. (doi:10.1016/j.fertnstert.2006.03.054)
198. Weinstein LS, Liu J, Sakamoto A, Xie T & Chen M 2004 Minireview: GNAS: normal and abnormal functions. Endocrinology 145 5459-5464. (doi:10.1210/en.2004-0865)
199. Welt CK 2008 Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clinical Endocrinology 68 499-509. (doi:10.1111/j.1365-2265.2007.03073.x)
200. Wilson T, Wu XY, Juengel JL, Ross IK, Lumsden JM, Lord EA, Dodds KG, Walling GA, McEwan JC, O'Connell AR et al. 2001 Highly prolific Booroola sheep have a mutation in the intracellular kinase domain of bone morphogenetic protein IB receptor (ALK-6) that is expressed in both oocytes and granulosa cells. Biology of Reproduction 64 1225-1235. (doi:10.1095/biolreprod64.4.1225) (Pubitemid 32239195)
201. Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, Corrigan EC, Simpson JL & Nelson LM 2007 The FMR1 premutation and reproduction. Fertility and Sterility 87 456-465. (doi:10.1016/j.fertnstert. 2006.09.004)
202. Woad KJ, Pearson SM, Harris SE, Gersak K & Shelling AN 2009 Investigating the association between inhibin alpha gene promoter polymorphisms and premature ovarian failure. Fertility and Sterility 91 62-66. (doi:10.1016/j.fertnstert.2007.11.012)
203. Yan C, Wang P, DeMayo J, DeMayo FJ, Elvin JA, Carino C, Prasad SV, Skinner SS, Dunbar BS, Dube JL et al. 2001 Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Molecular Endocrinology 15 854-866. (doi:10.1210/ me.15.6.854)
204. Yi SE, LaPolt PS, Yoon BS, Chen JY-C, Lu JKH & Lyons KM 2001 The type I BMP receptor BmprIB is essential for female reproductive function. PNAS 98 7994-7999. (doi:10.1073/pnas.141002798)
205. Zhao XX, Suzumori N, Yamaguchi M & Suzumori K 2005 Mutational analysis of the homeobox region of the human NOBOX gene in Japanese women who exhibit premature ovarian failure. Fertility and Sterility 83 1843-1844. (doi:10.1016/ j.fertnstert.2004.12.031)
206. Zhao H, Qin Y, Kovanci E, Simpson JL, Chen ZJ & Rajkovic A 2007 Analyses of GDF9 mutation in 100 Chinese women with premature ovarian failure. Fertility and Sterility 88 1474-1476. (doi:10.1016/ j.fertnstert.2007.01.021)
207. Zhao H, Chen ZJ, Qin Y, Shi Y, Wang S, Choi Y, Simpson JL & Rajkovic A 2008a Transcription factor FIGLA is mutated in patients with premature ovarian failure. American Journal of Human Genetics 82 1342-1348. (doi:10.1016/j.ajhg. 2008.04.018)
208. Zhao ZZ, Painter JN, Palmer JS, Webb PM, Hayward NK, Whiteman DC, Boomsma DI, Martin NG, Duffy DL & Montgomery GW 2008b Variation in bone morphogenetic protein 15 is not associated with spontaneous human dizygotic twinning. Human Reproduction 23 2372-2379. (doi:10.1093/humrep/den268)
209. Zhou S, Wang B, Ni F, Wang J, Cao Y & Ma X 2010 GPR3 may not be a potential candidate gene for premature ovarian failure. Reproductive Biomedicine Online 20 53-55. (doi:10.1016/j.rbmo.2009.10.013)
210. Zinn AR 2001 The X chromosome and the ovary. Journal of the Society for Gynecologic Investigation 8 S34-S36. (doi:10.1016/S1071- 5576(00)00104-0)
211. Zinn AR & Ross JL 1998 Turner syndrome and haploinsufficiency. Current Opinion in Genetics and Development 8 322-327. (doi:10.1016/ S0959-437X(98)80089-0)
212. Zinn AR, Tonk VS, Chen Z, Flejter WL, Gardner HA, Guerra R, Kushner H, Schwartz S, Sybert VP, Van Dyke DL et al. 1998 Evidence for a Turner syndrome locus or loci at Xp11.2-p22.1. American Journal of Human Genetics 63 1757-1766. (doi:10.1086/302152)